SCHEMBL1784470

SCHEMBL1784470

CCCCCC(C)(C)OC(C)(C)CCCCC

nearest known ligand 0.39

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
THRB P10828 1/20 0.39
FDPS P14324 11/20 0.36
GGPS1 O95749 7/20 0.36
SMPD1 P17405 4/20 0.35
CES2 O00748 1/20 0.33
LPAR1 Q92633 1/20 0.33
LPAR3 Q9UBY5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26106465 0.97 TSHR (0.44) TSHRTHRBFDPSGGPS1SMPD1
SCHEMBL20299931 0.97 TSHR (0.44) TSHRTHRBFDPSGGPS1SMPD1
SCHEMBL11696332 0.97 TSHR (0.44) TSHRTHRBFDPSGGPS1SMPD1
SCHEMBL2883813 0.97 TSHR (0.44) TSHRTHRBFDPSGGPS1SMPD1
SCHEMBL17124832 0.97 TSHR (0.44) TSHRTHRBFDPSGGPS1SMPD1
SCHEMBL7208110 0.97 TSHR (0.44) TSHRTHRBFDPSGGPS1SMPD1
SCHEMBL20299935 0.97 TSHR (0.44) TSHRTHRBFDPSGGPS1SMPD1
SCHEMBL6658765 0.97 TSHR (0.44) TSHRTHRBFDPSGGPS1SMPD1
SCHEMBL11699499 0.97 TSHR (0.44) TSHRTHRBFDPSGGPS1SMPD1
SCHEMBL9005784 0.97 TSHR (0.44) TSHRTHRBFDPSGGPS1SMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240417549-A1 Crosslinked Rubber Composition and Method for Producing Crosslinked Rubber Composition JAPAN ELASTOMER CO., LTD. (JP) 2024-12-19 US disclosed
EP-4417647-A1 CROSSLINKED RUBBER COMPOSITION AND METHOD FOR PRODUCING CROSSLINKED RUBBER COMPOSITION Japan Elastomer Co., Ltd. (JP) 2024-08-21 EP disclosed
WO-2023171325-A1 METHOD FOR PRODUCING ALKENE 株式会社クレハ 2023-09-14 WO disclosed
WO-2023171326-A1 METHOD FOR PRODUCING ALKENE 株式会社クレハ 2023-09-14 WO disclosed
US-11186531-B2 Production method for alkene KUREHA CORPORATION (JP) 2021-11-30 US disclosed
US-20210047252-A1 PRODUCTION METHOD FOR ALKENE KUREHA CORPORATION (JP) 2021-02-18 US disclosed
WO-2019176151-A1 PRODUCTION METHOD FOR ALKENE 株式会社クレハ 2019-09-19 WO disclosed
US-20110124575-A1 METHOD FOR PROCESSING MICROBIOLOGICALLY PRODUCED CYCLIC OLIGOPEPTIDES SANDOZ AG (CH) 2011-05-26 US disclosed
WO-2010144080-A1 IMPROVED CATALYST FLOW BASF CATALYSTS LLC (US) 2010-12-16 WO disclosed
US-7638585-B2 Catalyst flow BASF CATALYSTS, LLC (US) 2009-12-29 US disclosed
US-6365694-B1 COPOLYMERS OF VINYLCYCLOHEXANE WITH SYNDIOTACTIC CONFIGURATION IN WHICH THE QUANTITY OF DIADS IS GREATER THAN 50.1% WITH HIGH TRANSPARENCY, LOW BIREFRINGENCE AND HIGH HEAT DEFECTION TEMPERATURE, AND CAN BE USED FOR MOLDINGS BAYER AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1169431-A2 BACTERIAL CULTURE SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 2002-01-09 EP disclosed
WO-2000063343-A2 BACTERIAL CULTURE SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2000-10-26 WO disclosed
EP-0646103-B1 BF3-TERTIARY ETHERATE COMPLEXES FOR ISOBUTYLENE POLYMERIZATION AMOCO CORP (US) 1997-08-27 EP disclosed
EP-0646103-A4 BF 3?-TERTIARY ETHERATE COMPLEXES FOR ISOBUTYLENE POLYMERIZATION. AMOCO CORP (US) 1995-08-09 EP disclosed
EP-0646103-A1 BF 3?-TERTIARY ETHERATE COMPLEXES FOR ISOBUTYLENE POLYMERIZATION. AMOCO CORP (US) 1995-04-05 EP disclosed
WO-1993010063-A1 BF3-TERTIARY ETHERATE COMPLEXES FOR ISOBUTYLENE POLYMERIZATION AMOCO CORPORATION (US) 1993-05-27 WO disclosed
US-5068490-A Alkyl tert-butyl ether boron trifluoride complex as a catalyst AMOCO CORPORATION (US) 1991-11-26 US disclosed
US-4371725-A Process for the preparation of tertiary olefins and n-alkanols EC ERDOLCHEMIE GMBH (DE) 1983-02-01 US disclosed
US-4108963-A SOLVENT EXTRACTION PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1978-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210047252-A1 PRODUCTION METHOD FOR ALKENE ALK, ALKBH3, ALKBH1 TSHR 3005/4885THRB 4240/4885FDPS 170/4885
US-11186531-B2 Production method for alkene ALK, ALKBH3, ALKBH1 TSHR 3005/4885THRB 4240/4885FDPS 170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.